Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 15 02:53PM ET
8.57
Dollar change
+0.34
Percentage change
4.13
%
IndexRUT P/E- EPS (ttm)-0.92 Insider Own7.96% Shs Outstand48.09M Perf Week8.07%
Market Cap419.24M Forward P/E190.23 EPS next Y0.05 Insider Trans178.32% Shs Float45.03M Perf Month5.54%
Income-45.65M PEG- EPS next Q-0.23 Inst Own93.78% Short Float11.63% Perf Quarter-13.35%
Sales62.02M P/S6.76 EPS this Y28.54% Inst Trans-7.37% Short Ratio15.70 Perf Half Y-11.56%
Book/sh3.96 P/B2.16 EPS next Y106.30% ROA-11.29% Short Interest5.24M Perf Year-5.41%
Cash/sh1.96 P/C4.36 EPS next 5Y- ROE-19.27% 52W Range7.44 - 11.71 Perf YTD-23.75%
Dividend Est.- P/FCF- EPS past 5Y24.22% ROI-19.33% 52W High-26.81% Beta0.26
Dividend TTM- Quick Ratio5.20 Sales past 5Y0.23% Gross Margin90.08% 52W Low15.19% ATR (14)0.22
Dividend Ex-Date- Current Ratio5.20 EPS Y/Y TTM75.39% Oper. Margin-62.82% RSI (14)63.40 Volatility2.92% 2.36%
Employees99 Debt/Eq0.24 Sales Y/Y TTM20.97% Profit Margin-73.62% Recom2.20 Target Price13.20
Option/ShortYes / Yes LT Debt/Eq0.22 EPS Q/Q-22.86% Payout- Rel Volume0.26 Prev Close8.23
Sales Surprise-7.28% EPS Surprise-64.25% Sales Q/Q3.69% EarningsAug 05 AMC Avg Volume333.66K Price8.57
SMA205.50% SMA505.67% SMA200-4.21% Trades Volume73,922 Change4.13%
Date Action Analyst Rating Change Price Target Change
Aug-06-24Downgrade Leerink Partners Outperform → Market Perform $15 → $10
Apr-12-24Initiated BTIG Research Buy $21
Jan-08-24Downgrade Evercore ISI Outperform → In-line
May-23-22Initiated SVB Leerink Outperform $12
Nov-05-21Upgrade JP Morgan Underweight → Neutral $12
Sep-15-21Downgrade JP Morgan Overweight → Underweight $7
Aug-25-21Downgrade Morgan Stanley Overweight → Underweight $27 → $14
Aug-24-21Downgrade Cowen Outperform → Market Perform $42 → $14
Oct-14-20Upgrade Morgan Stanley Equal-Weight → Overweight $32
Jul-07-20Initiated JP Morgan Overweight $29
Sep-10-24 11:01AM
Sep-04-24 11:30AM
Aug-27-24 06:00AM
Aug-14-24 05:03PM
Aug-06-24 10:56AM
06:00PM Loading…
Aug-05-24 06:00PM
04:05PM
Jul-25-24 06:00AM
Jul-22-24 06:00AM
Jun-26-24 11:28AM
Jun-21-24 09:55AM
Jun-12-24 11:30AM
Jun-11-24 10:50AM
May-15-24 03:56PM
May-14-24 12:06PM
08:54PM Loading…
May-13-24 08:54PM
05:25PM
05:15PM
04:05PM
May-09-24 06:00AM
Apr-29-24 06:00AM
Apr-15-24 02:19PM
07:47AM
Apr-10-24 06:00AM
Mar-27-24 11:30AM
Mar-12-24 03:59PM
Feb-28-24 10:35AM
Feb-27-24 11:47AM
Feb-26-24 05:25PM
04:39PM
04:05PM Loading…
04:05PM
Feb-22-24 06:00AM
Feb-14-24 06:00AM
Jan-12-24 09:35AM
Jan-05-24 06:00AM
Dec-24-23 01:08PM
Dec-21-23 05:00PM
Dec-18-23 06:00AM
Dec-07-23 11:30AM
Nov-22-23 09:14AM
Nov-16-23 06:00AM
Nov-15-23 06:00AM
Nov-13-23 08:00AM
Nov-08-23 02:10PM
11:35AM
Nov-07-23 06:09PM
04:28PM
Oct-19-23 06:00AM
Sep-06-23 11:30AM
Aug-31-23 05:55PM
Aug-29-23 06:00AM
Aug-28-23 06:05AM
Aug-09-23 06:25AM
Aug-08-23 09:54AM
Aug-07-23 05:25PM
04:25PM
04:05PM
Aug-01-23 10:00AM
Jul-24-23 06:00AM
Jul-03-23 09:00AM
Jun-08-23 11:14AM
Jun-07-23 11:30AM
May-18-23 01:50PM
May-11-23 03:41PM
10:45AM
May-10-23 11:34AM
06:03AM
May-09-23 06:00PM
09:24AM
May-08-23 05:55PM
04:05PM
May-04-23 10:00AM
May-01-23 10:01AM
Apr-24-23 06:00AM
Apr-19-23 02:42PM
Apr-17-23 07:47AM
Apr-14-23 04:23AM
Apr-11-23 04:05PM
Apr-10-23 06:00AM
Mar-31-23 12:41PM
11:30AM
Mar-30-23 05:22PM
11:30AM
Mar-29-23 11:30AM
Mar-10-23 06:56AM
Mar-08-23 02:50PM
Mar-02-23 06:00AM
Feb-28-23 02:17PM
01:33PM
Feb-27-23 06:15PM
04:05PM
11:26AM
09:00AM
Feb-23-23 07:46AM
Feb-21-23 06:00AM
Feb-16-23 10:01AM
Feb-15-23 10:00AM
Feb-09-23 06:00AM
Jan-09-23 06:00AM
Dec-25-22 09:39AM
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Samaha Eli10% OwnerAug 07 '24Buy7.80999,8007,798,4409,511,150Aug 09 06:02 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSJul 10 '24Sale9.004,00036,000335,965Jul 12 06:15 PM
Samaha Eli10% OwnerMay 01 '24Buy8.751,499,12413,117,3358,511,350May 03 04:19 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSFeb 22 '24Sale8.711,25410,922311,733Feb 22 08:04 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSNov 21 '23Sale10.291,37814,180331,206Nov 22 06:07 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTNov 14 '23Sale10.222,48225,366346,839Nov 16 06:16 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTOct 16 '23Sale9.032,48222,412334,321Oct 18 06:54 PM